Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 1668565-74-9 Chemical Structure| 1668565-74-9

Structure of PCC0208009
CAS No.: 1668565-74-9

Chemical Structure| 1668565-74-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

IDO-IN-2 is an IDO inhibitor with IC50 value of 68 nM and 160 nM in HeLa cell and HEK293 cell, respectively.

Synonyms: IDO-IN-2; IDO inhibitor 1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PCC0208009

CAS No. :1668565-74-9
Formula : C29H35N7O
M.W : 497.63
SMILES Code : O=C(NC1=CC=C(C)C=C1)NC2=CC(C3=CC=CC=C3C4=NNN=N4)=CC=C2N(CC(C)C)CC(C)C
Synonyms :
IDO-IN-2; IDO inhibitor 1
MDL No. :MFCD30728441
InChI Key :CJNMMPAEIYFQIJ-UHFFFAOYSA-N
Pubchem ID :90718185

Safety of PCC0208009

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H228
Precautionary Statements:P210-P240-P280-P370+P378-P403-P501
Class:4.1
UN#:1325
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HeLa cells 100 nM 0.5, 1, 2, 5, 10, 24, 48, 72 hours Evaluate the inhibitory effects of PCC0208009 on IDO activity. Results showed that PCC effectively inhibited IDO activity to the level of the vehicle group, lasting for at least 72 hours. Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418787991
HeLa cells 50, 100, 200 nM 48 hours Evaluate the effects of PCC0208009 on IDO expression. Results showed that PCC dose-dependently suppressed IFN-γ-induced IDO protein and mRNA expression. Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418787991
HeLa cells 0.3-5000 nM 48 hours Evaluate the inhibitory effect of PCC0208009 on IDO activity, results showed PCC0208009 effectively inhibited IDO activity at 2 nM Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420950584
HeLa cells 25, 50, 100, 200 nM 72 hours Evaluate the effects of PCC0208009 on the viability and proliferation of HeLa cells. Results showed that 25-200 nM PCC or/and 100 ng/mL IFN-γ had no obvious effects on the viability and proliferation of HeLa cells. Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418787991
PBMC cells 1.6, 8, 40, 200, 1000 nM 96 hours Evaluate the effect of PCC0208009 on PBMC proliferation and activation, results showed PCC0208009 significantly promoted PBMC proliferation and cytokine secretion at 8 nM and above Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420950584

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice CT26 tumor model Oral administration 0.8 mmol/kg Twice daily for 7 days Evaluate the anti-tumor effect of PCC0208009 in vivo, results showed PCC0208009 significantly suppressed tumor growth and promoted immune cell activation Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420950584
C57BL/6J mice GL261 heterotopic model Oral 100 mg/kg Twice daily, until the end of the study Evaluate the anti-tumor effects of PCC0208009 in combination with TMZ. Results showed that PCC significantly enhanced the anti-tumor effects of TMZ, inhibiting tumor growth and increasing the proportion of T cells within tumors. Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418787991

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.01mL

0.40mL

0.20mL

10.05mL

2.01mL

1.00mL

20.10mL

4.02mL

2.01mL

References

 

Historical Records

Categories